CVS Group plc

CVS Group plc

1,305.00
GBX
+6.00
(+0.46%)
90.79BMarket Cap
Mar 04Next Earn
CVS Group plc
LSE:CVSG
(London Stock Exchange)

Recent

price

1,305.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
GBP
1.6
1.8
1.92
2.11
2.48
2.84
3.65
4.38
4.93
5.77
6.05
7.22
7.81
8.26
8.92
- -
- -
Revenue per Share
0.06
0.06
0.05
0.07
0.08
0.12
0.12
0.19
0.16
0.12
0.08
0.27
0.36
0.59
0.09
- -
- -
Basic EPS, GAAP
0.13
0.22
0.13
0.16
0.2
0.21
0.27
0.26
0.4
0.4
0.92
0.62
0.72
0.54
0.34
- -
- -
Free Cash Flow per Basic Share
- -
- -
0.01
0.01
0.02
0.03
0.03
0.03
0.04
0.05
0.06
- -
0.06
0.07
0.08
- -
- -
Dividend per Share
0.21
0.29
0.36
0.43
0.54
0.66
0.78
1.38
2.24
2.31
2.36
2.7
3.06
3.6
3.63
- -
4.17
Book Value per Share
-0.79
-0.67
-0.57
-0.5
-0.47
-0.68
-1.42
-1.24
-0.65
-1.15
-0.89
-0.53
0.01
0.01
-1.04
- -
-1.01
Tangible Book Value per Share
53
56
57
57
58
59
60
62
66
71
71
71
71
71
72
72
72
Basic Weighted Avg Shares
86
101
109
120
143
167
218
272
327
407
428
510
554
589
639
- -
- -
Sales/Revenue/Turnover
7.26
6.26
6.26
5.58
5.25
5.86
5.41
6.33
5.41
3.84
4.32
7.86
7.72
11.61
7.48
- -
- -
Operating Margin (%)
6
8
8
9
10
12
19
22
26
31
46
48
48
50
59
- -
- -
Depreciation Expense
3
3
3
4
5
7
7
12
11
8
6
19
26
42
6
- -
- -
Net Income, GAAP
20.34
18.03
23.68
27.27
23.81
20
23.08
20.69
24.11
29.91
42.42
41.69
28.61
19.77
33.52
- -
- -
Effective Tax Rate (%)
3.58
3.44
2.67
3.33
3.36
4.06
3.21
4.23
3.27
2.02
1.33
3.78
4.64
7.11
1
- -
- -
Profit Margin (%)
-9
-7
-1
-3
-10
-20
-5
-4
9
2
-18
3
27
7
11
- -
9
Working Capital
37
33
36
34
30
35
100
104
84
114
173
174
179
186
274
- -
257
LT Debt
12
17
20
25
31
39
47
88
158
163
167
191
217
257
261
- -
300
Total Equity
9.08
9.26
8.82
7.78
8.48
9.67
7.34
7.61
5.9
4.04
3.22
6.19
7.56
12.22
6.11
- -
- -
Return on Invested Capital (%)
9.37
9.28
7.11
8.36
9.01
10.04
7.47
7.81
6.02
4.08
3.22
6.41
7.76
10.96
2.86
- -
- -
Return on Capital (%)
48.83
24.37
15.73
17.78
17.17
19.35
16.34
17.09
8.71
5.11
3.46
10.79
12.58
17.66
2.47
- -
- -
Return on Common Equity (%)

Capital Structure

GBP

•

in mil. unless spec.
Dec'25
Jun'25
Dec'26
ST Debt
14
- -
16
LT Borrowings
192
- -
171
LT Finance Leases
90
- -
86
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
72
72
71
Market Capitalization
603
897
908

Working Capital

GBP

•

in mil. unless spec.
Dec'25
Jun'25
Dec'26
Total Current Assets
125
- -
128
Cash, Cash Equivalents & STI
12
- -
12
Accounts Receivable, Net
61
- -
69
Inventories
30
- -
31
Total Current Liabilities
116
- -
120
Payables & Accruals
- -
- -
- -
ST Debt
14
- -
16
Deferred Revenue
- -
- -
- -

Growth Rates

GBP

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
639
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Earnings Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.09
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Dividends Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.08
2025
- -
- -
- -
2026
- -
- -
- -
Business
CVS Group plc is a leading provider of integrated veterinary services, encompassing a wide array of animal care offerings. The company operates through distinct divisions: Veterinary Practices, Laboratories, Crematoria, and an Online Retail Business. It manages numerous veterinary practices that deliver first-opinion treatment, specialist referral services, and out-of-hours emergency care for companion, equine, and farm animals across the United Kingdom and Australia. The Laboratories segment provides comprehensive diagnostic services, including biochemistry, hematology, and histology, supporting both its own practices and external veterinary clinics. Its Crematoria division offers pet cremation and clinical waste disposal services to veterinary practices and directly to pet owners. Additionally, the Animed Direct online retail platform supplies prescription and non-prescription medications, premium pet foods, and various pet care products. The group also manages pet health plans like The Healthy Pet Club, operates buying groups, and offers veterinary consumables. As of recent reports, CVS Group encompasses approximately 500 veterinary practices, including referral hospitals and dedicated out-of-hours sites, alongside three diagnostic laboratories and seven crematoria. The company, founded in 1999 and headquartered in Diss, United Kingdom, is currently undertaking a strategic move from the AIM market to the Main Market of the London Stock Exchange in early 2026 and has initiated a £20 million share buyback program. It is also actively expanding its presence through acquisitions in the Australian veterinary market.

Company News

  • CVS Group plc (CVSGF) Q4 2026 Earnings Call Transcript

  • CVS Group plc (CVSGF) Q4 2026 Earnings Call Transcript

  • CVS Group plc (CVSGF) Q4 2026 Earnings Call Prepared Remarks Transcript

  • CVS Group plc (CVSGF) Discusses Capital Investments in Facilities, Clinical Equipment and Technology to Drive Returns Transcript

  • CVS Group Q4 Earnings Call Highlights

  • Converium Capital Sends Letter to CVS Group Board Highlighting Company's Undervaluation and Urging £100 Million Share Buyback

  • UK's CVS Group CEO to step down after 7 years at the helm

  • CVS Group plc (CVSGF) Shareholder/Analyst Call Transcript

  • CVS Group plc (CVSGF) Q2 2026 Earnings Call Prepared Remarks Transcript

  • UK's CVS Group plans Main Market move, approves near $27 million buyback

  • CVS Group plc (CVSGF) Q4 2025 Earnings Call Prepared Remarks Transcript

  • CVS Group plc (CVSGF) Q4 2025 Earnings Call Transcript

  • CVS Group earnings 'in line' with guidance as it awaits CMA outcome

  • Intel faces possible split, CVS group president: Market Domination